These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8178309)

  • 1. Fibrin as a factor in atherogenesis.
    Smith EB; Thompson WD
    Thromb Res; 1994 Jan; 73(1):1-19. PubMed ID: 8178309
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.
    Mitrophanov AY; Wolberg AS; Reifman J
    Mol Biosyst; 2014 Jul; 10(9):2347-57. PubMed ID: 24958246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation and fibrinolysis in gastric cancer.
    Repetto O; De Re V
    Ann N Y Acad Sci; 2017 Sep; 1404(1):27-48. PubMed ID: 28833193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human fibrinogen.
    Shafer JA; Higgins DL
    Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenesis and fibrinogen: historical perspective and current status.
    Pilgeram L
    Naturwissenschaften; 1993 Dec; 80(12):547-55. PubMed ID: 8302368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.
    Speiser W; Speiser P; Minar E; Korninger C; Niessner H; Huber K; Schernthaner G; Ehringer H; Lechner K
    Thromb Res; 1990 Jul; 59(1):77-88. PubMed ID: 2144671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque.
    Rabbani LE; Loscalzo J
    Atherosclerosis; 1994 Jan; 105(1):1-7. PubMed ID: 8155083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between blood coagulation markers, atherothrombosis and dementia.
    Gupta A; Pansari K
    Int J Clin Pract; 2003 Mar; 57(2):107-11. PubMed ID: 12661793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What drives "fibrinolysis"?
    Medcalf RL
    Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and the control of blood coagulation.
    Chapin JC; Hajjar KA
    Blood Rev; 2015 Jan; 29(1):17-24. PubMed ID: 25294122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
    Hoppe B
    Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of hemostatic factors in atherogenesis].
    Gensini GF; Prisco D; Falciani M; Giusti B
    Cardiologia; 1997 Oct; 42(10):1007-19. PubMed ID: 9534275
    [No Abstract]   [Full Text] [Related]  

  • 17. Exercise and hemostasis in humans.
    Streiff M; Bell WR
    Semin Hematol; 1994 Apr; 31(2):155-65. PubMed ID: 8066472
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of parameters of the blood coagulation and fibrinolytic system in patients with peripheral arteriosclerotic angio-organopathy and in patients after acute phlebothrombosis].
    Siegert G; Runge E
    Vasa Suppl; 1992; 35():89-91. PubMed ID: 1481076
    [No Abstract]   [Full Text] [Related]  

  • 19. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods.
    Satterwhite TK; Hawiger J; Burklow SL; Koenig MG
    J Infect Dis; 1973 Apr; 127(4):437-41. PubMed ID: 4694546
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
    Hrubisková K
    Bratisl Lek Listy; 1974; 62(1):111-9. PubMed ID: 4603642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.